Clinical assessment and management of sleep disorders in multiple sclerosis: A literature review

Acta Neurologica Scandinavica

Volumn 127, Issue S196, 2013, Pages 24-30

  Lunde, H M B ^a   Bjorvatn, B ^a,b   Myhr, K M ^a,b   Bo L ^a,b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Circadian rhythm disorders; Insomnia; Multiple sclerosis; Narcolepsy; Obstructive sleep apnea; REM sleep behavior disorder; Restless legs syndrome

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE; CLONAZEPAM; DOPAMINE RECEPTOR STIMULATING AGENT; MELATONIN; METHYLPHENIDATE; METHYLPREDNISOLONE; MODAFINIL; OPIATE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; ZOPICLONE;

CATAPLEXY; CIRCADIAN RHYTHM SLEEP DISORDER; CLINICAL ASSESSMENT; CLINICAL FEATURE; COGNITIVE THERAPY; DISEASE ASSOCIATION; DRUG MEGADOSE; HUMAN; HYPERSOMNIA; HYPNAGOGIC HALLUCINATION; INSOMNIA; MEDICAL LITERATURE; MORBIDITY; MULTIPLE SCLEROSIS; NARCOLEPSY; PARASOMNIA; PATHOPHYSIOLOGY; PERIODIC LIMB MOVEMENT DISORDER; PREVALENCE; REVIEW; SLEEP DISORDER; SLEEP DISORDERED BREATHING; SLEEP RELATED MOVEMENT DISORDER; MEDLINE; STATISTICS;

HUMANS; MEDLINE; MULTIPLE SCLEROSIS; PUBMED; SLEEP DISORDERS;

EID: 84870436176     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/ane.12046     Document Type: Review

References (67)

1. Bamer AM, Johnson KL, Amtmann D, Kraft GH. Prevalence of sleep problems in individuals with multiple sclerosis. Mult Scler 2008;14:1127-1130.
2. Merlino G, Fratticci L, Lenchig C et al. Prevalence of 'poor sleep' among patients with multiple sclerosis: an independent predictor of mental and physical status. Sleep Med 2009;10:26-34.
3. Pedrosa RP, Drager LF, Gonzaga CC et al. Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension 2011;58:811-817.
4. Hargens TA, Guill SG, Kaleth AS et al. Insulin resistance and adipose-derived hormones in young men with untreated obstructive sleep apnea. Sleep Breath 2012; DOI:10.1007/S11325-012-0708-0.
5. Grandner MA, Jackson NJ, Pak VM, Gehrman PR. Sleep disturbance is associated with cardiovascular and metabolic disorders. J Sleep Res 2011;21:427-433.
6. Caminero A, Bartolome M. Sleep disturbances in multiple sclerosis. J Neurol Sci 2011;309:86-91.
7. Plazzi G, Montagna P. Remitting REM sleep behavior disorder as the initial sign of multiple sclerosis. Sleep Med 2002;3:437-439.
8. Iseki K, Mezaki T, Oka Y et al. Hypersomnia in MS. Neurology 2002;59:2006-2007.
9. Manconi M, Ferini-Strambi L, Filippi M et al. Multicenter case-control study on restless legs syndrome in multiple sclerosis: the REMS study. Sleep 2008;31:944-952.
10. Vavrova J, Kemlink D, Sonka K et al. Restless legs syndrome in Czech patients with multiple sclerosis: an epidemiological and genetic study. Sleep Med 2012;13:848-851.
11. Morin CM, Benca R. Chronic insomnia. Lancet 2012;379:1488.
12. Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med 2008;4:487-504.
13. Stanton BR, Barnes F, Silber E. Sleep and fatigue in multiple sclerosis. Mult Scler 2006;12:481-486.
14. Tachibana N, Howard RS, Hirsch NP, Miller DH, Moseley IF, Fish D. Sleep problems in multiple sclerosis. Eur Neurol 1994;34:320-323.
15. Crayton H, Heyman RA, Rossman HS. A multimodal approach to managing the symptoms of multiple sclerosis. Neurology 2004;63(11 Suppl 5):S12-S18.
16. Culpepper L. Secondary insomnia in the primary care setting: review of diagnosis, treatment, and management. Curr Med Res Opin 2006;22:1257-1268.
17. Baron KG, Corden M, Jin L, Mohr DC. Impact of psychotherapy on insomnia symptoms in patients with depression and multiple sclerosis. J Behav Med 2011;34:92-101.
18. Bjorvatn B, Pallesen S. A practical approach to circadian rhythm sleep disorders. Sleep Med Rev 2009;13:47-60.
19. Martinez D, Lenz Mdo C. Circadian rhythm sleep disorders. Indian J Med Res 2010;131:141-149.
20. Taphoorn MJ, van Someren E, Snoek FJ et al. Fatigue, sleep disturbances and circadian rhythm in multiple sclerosis. J Neurol 1993;240:446-448.
21. Qiu W, Raven S, Wu JS et al. Hypothalamic lesions in multiple sclerosis. J Neurol Neurosurg Psychiatry 2011;82:819-822.
22. Huitinga I, Erkut ZA, van Beurden D, Swaab DF. Impaired hypothalamus-pituitary-adrenal axis activity and more severe multiple sclerosis with hypothalamic lesions. Ann Neurol 2004;55:37-45.
23. Dyken ME, Afifi AK, Lin-Dyken DC. Sleep-related problems in neurologic diseases. Chest 2012;141:528-544.
24. Deriu M, Cossu G, Molari A et al. Restless legs syndrome in multiple sclerosis: a case-control study. Mov Disord 2009;24:697-701.
25. Ferini-Strambi L, Filippi M, Martinelli V et al. Nocturnal sleep study in multiple sclerosis: correlations with clinical and brain magnetic resonance imaging findings. J Neurol Sci 1994;125:194-197.
26. Auger C, Montplaisir J, Duquette P. Increased frequency of restless legs syndrome in a French-Canadian population with multiple sclerosis. Neurology 2005;65:1652-1653.
27. Manconi M, Fabbrini M, Bonanni E et al. High prevalence of restless legs syndrome in multiple sclerosis. Eur J Neurol: the official journal of the European Federation of Neurological Societies 2007;14:534-539.
28. Manconi M, Rocca MA, Ferini-Strambi L et al. Restless legs syndrome is a common finding in multiple sclerosis and correlates with cervical cord damage. Mult Scler 2008;14:86-93.
29. Li Y, Munger KL, Batool-Anwar S, De Vito K, Ascherio A, Gao X. Association of multiple sclerosis with restless legs syndrome and other sleep disorders in women. Neurology 2012;78:1500-1506.
30. Allen RP, Earley CJ. The role of iron in restless legs syndrome. Mov Disord 2007;22(Suppl 18):S440-S448.
31. Hornyak M, Scholz H, Kiemen A, Kassubek J. Investigating the response to intravenous iron in restless legs syndrome: an observational study. Sleep Med 2012;13:732-735.
32. Sivam S, Yee BJ. Role of gabapentin enacarbil XR in restless legs syndrome. Ther Clin Risk Manag 2012;8:201-208.
33. Steffen A, Hagenah J, Wollenberg B, Bruggemann N. [Central sleep apnea in multiple sclerosis]. Hno 2010;58:405-408.
34. Veauthier C, Paul F. Fatigue in multiple sclerosis: which patient should be referred to a sleep specialist? Mult Scler 2011;18:284-289.
35. Dias RA, Hardin KA, Rose H, Agius MA, Apperson ML, Brass SD. Sleepiness, fatigue, and risk of obstructive sleep apnea using the STOP-BANG questionnaire in multiple sclerosis: a pilot study. Sleep Breath 2012; DOI:10.1007/S11325-011-0642-6.
36. Kaminska M, Kimoff RJ, Schwartzman K, Trojan DA. Sleep disorders and fatigue in multiple sclerosis: evidence for association and interaction. J Neurol Sci 2011;302:7-13.
37. Kaminska M, Kimoff R, Benedetti A et al. Obstructive sleep apnea is associated with fatigue in multiple sclerosis. Mult Scler 2011;18:8:1159-69.
38. Auer RN, Rowlands CG, Perry SF, Remmers JE. Multiple sclerosis with medullary plaques and fatal sleep apnea (Ondine's curse). Clin Neuropathol 1996;15:101-105.
39. Howard RS, Wiles CM, Hirsch NP, Loh L, Spencer GT, Newsom-Davis J. Respiratory involvement in multiple sclerosis. Brain 1992;115(Pt 2):479-494.
40. Braley TJ, Segal BM, Chervin RD. Sleep-disordered breathing in multiple sclerosis. Neurology 2012;79:929-936.
41. Ho ML, Brass SD. Obstructive sleep apnea. Neurol Int 2011;3:e15.
42. Dyken ME, Yamada T. Narcolepsy and disorders of excessive somnolence. Prim Care 2005;32:389-413.
43. Morrison I, Riha RL. Excessive daytime sleepiness and narcolepsy-an approach to investigation and management. Eur J Intern Med 2012;23:110-117.
44. Nohynek H, Jokinen J, Partinen M et al. AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS ONE 2012;7:e33536.
45. Vrethem M, Malmgren K, Lindh J. A patient with both narcolepsy and multiple sclerosis in association with Pandemrix vaccination. J Neurol Sci 2012;321:89-91.
46. Nishino S, Kanbayashi T. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Sleep Med Rev 2005;9:269-310.
47. Oka Y, Kanbayashi T, Mezaki T et al. Low CSF hypocretin-1/orexin-A associated with hypersomnia secondary to hypothalamic lesion in a case of multiple sclerosis. J Neurol 2004;251:885-886.
48. Berg O, Hanley J. Narcolepsy in two cases of multiple sclerosis. Acta Neurol Scand 1963;39:252-256.
49. Vetrugno R, Stecchi S, Plazzi G et al. Narcolepsy-like syndrome in multiple sclerosis. Sleep Med 2009;10:389-391.
50. Schrader H, Gotlibsen OB, Skomedal GN. Multiple sclerosis and narcolepsy/cataplexy in a monozygotic twin. Neurology 1980;30:105-108.
51. Brass SD, Duquette P, Proulx-Therrien J, Auerbach S. Sleep disorders in patients with multiple sclerosis. Sleep Med Rev 2010;14:121-129.
52. Nishino S, Okuro M. Emerging treatments for narcolepsy and its related disorders. Expert Opin Emerg Drugs 2010;15:139-158.
53. Morrison I, Buskova J, Nevsimalova S, Douglas NJ, Riha RL. Diagnosing narcolepsy with cataplexy on history alone: challenging the International Classification of Sleep Disorders (ICSD-2) criteria. Eur J Neurol: the official journal of the European Federation of Neurological Societies 2011;18:1017-1020.
54. Billiard M, Bassetti C, Dauvilliers Y et al. EFNS guidelines on management of narcolepsy. Eur J Neurol: the official journal of the European Federation of Neurological Societies 2006;13:1035-1048.
55. Zanigni S, Calandra-Buonaura G, Grimaldi D, Cortelli P. REM behaviour disorder and neurodegenerative diseases. Sleep Med 2011;12(Suppl 2):S54-S58.
56. Gomez-Choco MJ, Iranzo A, Blanco Y, Graus F, Santamaria J, Saiz A. Prevalence of restless legs syndrome and REM sleep behavior disorder in multiple sclerosis. Mult Scler 2007;13:805-808.
57. Tippmann-Peikert M, Boeve BF, Keegan BM. REM sleep behavior disorder initiated by acute brainstem multiple sclerosis. Neurology 2006;66:1277-1279.
58. Anderson KN, Shneerson JM. Drug treatment of REM sleep behavior disorder: the use of drug therapies other than clonazepam. J Clin Sleep Med 2009;5:235-239.
59. Gilhus NE, Barnes M, Brainin M. Sleep Disorders in Neurodegenerative Disorders and Stroke. European Handbook of Neurological Management, 2nd edn, Vol. 1, chapter 39, 2010.
60. Kaynak H, Altintas A, Kaynak D et al. Fatigue and sleep disturbance in multiple sclerosis. Eur J Neurol: the official journal of the European Federation of Neurological Societies 2006;13:1333-1339.
61. Veauthier C, Radbruch H, Gaede G et al. Fatigue in multiple sclerosis is closely related to sleep disorders: a polysomnographic cross-sectional study. Mult Scler 2011;17:613-622.
62. Mendozzi L, Tronci F, Garegnani M, Pugnetti L. Sleep disturbance and fatigue in mild relapsing remitting multiple sclerosis patients on chronic immunomodulant therapy: an actigraphic study. Mult Scler 2010;16:238-247.
63. Nadjar Y, Coutelas E, Prouteau P et al. Injection of interferon-beta in the morning decreases flu-like syndrome in many patients with multiple sclerosis. Clin Neurol Neurosurg 2011;113:316-322.
64. Cronlein T, Geisler P, Langguth B et al. Polysomnography reveals unexpectedly high rates of organic sleep disorders in patients with prediagnosed primary insomnia. Sleep Breath 2011; DOI:10.1007/S11325-01+0608-8.
65. Hartmann M, Pfister R, Pfadenhauer K. Restless legs syndrome associated with spinal cord lesions. J Neurol Neurosurg Psychiatry 1999;66:688-689.
66. McNicholas WT. Diagnosis of obstructive sleep apnea in adults. Proc Am Thorac Soc 2008;5:154-160.
67. Kanbayashi T, Inoue Y, Chiba S et al. CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia. J Sleep Res 2002;11:91-93.